查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1475015

全球合成脂质市场评估：依形式、应用、地区、机会、预测（2017-2031）

Synthetic Lipids Market Assessment, By Form [Solid, Liquid], By Application [Personal Care and Cosmetics, Pharmaceuticals, Food], By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 229 Pages | 商品交期: 3-5个工作天内

价格

全球合成脂质市场规模预计将从 2023 年的 25.6 亿美元增至 2031 年的 39.3 亿美元，预计 2024-2031 年的复合年增长率为 5.5%。 个人护理产品和化妆品中合成脂质的使用不断增加以及製药行业的快速扩张支持了市场的扩张。

製药业对合成脂质的需求不断增加是扩大全球合成脂质市场规模的主要因素之一。 製药业对合成脂质的需求成长可归因于以下事实：合成脂质由单一脂质组成，并以其品质而闻名，与天然脂质相比具有多种优势。 另外，组织来源的脂质通常是牛或蛋来源的脂质的组合。 与组织来源的脂质不同，合成脂质不存在蛋白质或病毒污染的风险，且不存在批次间的差异。 此外，透过优化纯化技术和製造流程以及选择高品质的起始材料可以提高合成脂质的纯度。 因此，製药业的需求不断增加，支持了市场的扩大。

与各国政府和市场领导者的合作进一步为市场提供了利润丰厚的成长机会。 例如，2022 年 6 月，领先的特种化学品公司之一赢创宣布与美国政府合作投资 2.2 亿美元建设脂质生产设施，以生产基于 mRNA 的治疗药物。 Chippecanoe 位于印第安纳州拉斐特的工厂预计将实现灵活的脂质生产。 该项目计划于2023年初动工建设，并于2025年投入营运。

化妆品及个护产业扩张带动市场需求

世界各地个人对化妆品和个人护理产品的投资不断增加，正在为市场创造利润丰厚的成长机会。 例如，根据《富比士》2023年发表的文章，2022年美国化妆品市场规模约500亿美元。 预计这种增长将加强对合成脂质的需求并推动预测期内的市场扩张。 这种市场扩张可归因于胆固醇的特性，胆固醇对于形成健康的皮肤屏障至关重要。 它们通常被添加到修復屏障保湿霜中，以帮助它们有效发挥作用。 定期修復皮肤屏障对于防止经皮水分流失并保持过敏原、刺激物和细菌远离皮肤至关重要。 对虐待动物的认识不断增强以及对动物福利的担忧正在促使世界各地的人们转向纯素产品。 这些担忧推动了对个人护理产品和化妆品的需求，并且由于植物不会产生合成胆固醇，因此推动了对合成胆固醇的需求并支持市场扩张。 各种化妆品和个人护理製造商越来越多地采用合成胆固醇来为客户提供纯素屏障修復保湿霜，这增加了市场需求。

食品业不断增长的产品需求推动了市场需求

对商业母乳脂肪替代品 (HMFS) 的需求不断增长，对市场成长产生了积极影响。 母乳脂肪是主要的能量来源，约占婴儿每日热量摄取的50%。 它也是脂溶性维生素和重要脂肪酸的重要来源。 棕榈酸和油酸是母乳脂肪中的主要脂肪酸，分别占25%和40%。

然而，棕榈酸（一种水解游离脂肪酸）会与新生儿生长所需的矿物质和钙形成不溶性盐，并透过粪便排出，导致便秘并抑制钙的吸收。 因此，在配製HMFS时，必须调整棕榈酸的组成和用量。 市售的 HMFS 是一种含有脂肪酸的合成脂质，分布与人类乳脂肪相当。 因此，它是合成婴儿配方奶粉的重要原料。 例如，美国国际贸易委员会估计，全球婴儿配方奶粉出口额为96亿美元，出口量为100万吨（均不包括欧盟内部贸易）。 因此，婴儿配方奶粉需求的增加正在推动合成脂质的需求，推动市场成长。

本报告研究和分析了全球合成脂质市场，提供市场规模和预测、市场动态以及主要参与者的现状和前景。

目录

第一章研究方法

第 2 章专案范围与定义

第 3 章执行摘要

第 4 章顾客回馈

  • 市场认知度与产品讯息
  • 品牌知名度与忠诚度
  • 购买决策时考虑的因素
  • 购买频率
  • 购买介质

第五章全球合成脂质市场展望（2017-2031）

  • 市场规模与预测
    • 金额
    • 数量
  • 依形状
    • 固体
    • 液体
  • 依用途
    • 个人护理/化妆品
    • 医学
    • 食物
  • 依地区
    • 北美
    • 南美洲
    • 欧洲
    • 亚太地区
    • 中东/非洲
  • 市占率：依公司划分（2023 年）

第 6 章全球合成脂质市场前景：依地区划分（2017-2031 年）

  • 北美
    • 市场规模与预测
    • 依形状
    • 依用途
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 英国
    • 俄罗斯
    • 荷兰
    • 西班牙
    • 土耳其
    • 波兰
  • 亚太地区
    • 印度
    • 中国
    • 日本
    • 澳大利亚
    • 越南
    • 韩国
    • 印尼
    • 菲律宾
  • 南美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 南非

第七章供给面分析

  • 生产能力：依公司划分
  • 生产：依公司划分
  • 营运效率：依公司划分
  • 主要工厂地点（最多 25 个地点）

第 8 章市场地图（2023 年）

  • 依形状
  • 依用途
  • 依地区

第九章宏观环境与产业结构

  • 需求与供给分析
  • 进出口分析
  • 供应链分析
  • PESTEL 分析
  • 波特五力分析

第 10 章市场动态

  • 生长促进因素
  • 抑製成长的因素（问题、限制因素）

第十一章主要公司状况

  • 前 5 名市场领导者的竞争矩阵
  • 前 5 位市场领导者的市场收入分析（2023 年）
  • 併购/合资企业（如果适用）
  • SWOT 分析（5 家市场公司）
  • 专利分析（如果适用）

第十二章价格分析

第 13 章案例研究

第14章主要公司展望

  • CordenPharma
  • Sigma-Aldrich (Merck Group)
  • Merck Millipore
  • Avanti Polar Lipids, Inc
  • Lipoid GmbH
  • NOF EUROPE GmbH
  • Croda Pharma
  • NucleoSyn
  • Evonik Industries AG
  • ABITEC Corporation

第 15 章策略建议

第16章关于我们公司，免责声明

Product Code: MX11282

Global synthetic lipids market is projected to witness a CAGR of 5.5% during the forecast period 2024-2031, growing from USD 2.56 billion in 2023 to USD 3.93 billion in 2031F. The market expansion is supported by the increasing utilization of synthetic lipids in personal care and cosmetic products and rapid expansion of pharmaceutical sector.

The increasing demand for synthetic lipids by the pharmaceutical sector is one of the major factors augmenting the global synthetic lipids market size. The rising requirement of synthetic lipids by the pharmaceutical sector can be attributed to the various advantages offered by the synthetic lipids over their natural counterparts as they consist of a single lipid, the quality of which is known. Also, tissue-derived lipids are usually a combination of bovine-derived or egg-derived lipids. Synthetic lipids, unlike tissue-derived lipids, do not possess a risk of protein or viral contamination or show batch-to-batch variability. Additionally, the purity of synthetic lipids can be enhanced by optimizing the purification techniques and manufacturing processes and by selecting starting materials with superior quality. Thus, boosting their demand from the pharmaceutical sector and supporting the market expansion.

Collaborations between different governments and leading players of the market are further providing lucrative growth opportunities to the market. For instance, in June 2022, Evonik, one of the leading specialty chemicals companies announced an investment of USD 220 million in partnership with the government of the United States to build lipid production facility for producing mRNA-based therapies. The Tippecanoe site in Lafayette, Indiana is expected to ensure flexible lipid production. The construction for the project commenced in early 2023 and is expected to go onstream in 2025.

Expansion of the Cosmetics and Personal Care Industry Boosts Market Demand

The increasing investments by individuals in various regions across the globe in cosmetics and personal care products is providing lucrative growth opportunities to the market. For instance, according to an article published by Forbes in 2023, the value of the cosmetics market in the United States was approximately USD 50 billion in 2022. The growth will bolster the demand for synthetic lipids and aid the expansion of the market over the forecast period. The expansion can be attributed to the essential nature of cholesterol in making a healthy skin barrier. They are often added to barrier repair moisturizers to function effectively. Regular repair of the skin barrier is essential for preventing trans-dermal water loss and for keeping allergens, irritants, and bacteria away from the skin. Due to the growing awareness about animal cruelty and rising concerns about animal welfare, individuals across the globe are switching to vegan products due to increasing consciousness. Such concerns propel the requirement for personal care products and cosmetics and support the market expansion as they boost the demand for synthetic cholesterol as plants do not produce it. The increasing adoption of synthetic cholesterol by various cosmetic and personal care manufacturers to provide vegan barrier repair moisturizers to their customers is augmenting the market demand.

Increasing Product Requirement from Food Industry Boosts Global Synthetic Lipids Market Demand

The rising requirement for commercial human milk fat substitutes (HMFSs) is positively influencing the growth of the market. Human milk fat provides approximately 50% of babies' daily calorie intake and is their primary energy source. It is also an essential source of fat-soluble vitamins and vital fatty acids. Palmitic acid and oleic acid are the main fatty acids available in human milk fat, constituting up to 25% and 40%, respectively.

However, palmitic acid, a hydrolyzed free fatty acid forms an insoluble salt with the minerals and calcium that are required by the newborns for growth is excreted in feces, causing constipation, and preventing the absorption of calcium. Hence, it is essential to regulate the composition and amount of palmitic acid while formulating HMFSs. Commercial HMFSs are synthetic lipids that have a distribution comparable to that of human milk fat and contain fatty acids. Thus, making it an essential raw material in synthesis of infant food products (formula). For instance, according to the U.S. International Trade Commission estimates, the global infant and child formula exports were valued at USD 9.6 billion with a volume of 1 million mt (these figures exclude the intra-EU trade). Therefore, the increase in the requirement for infant formula is boosting the demand for synthetic lipids and aiding the market growth.

North America to Hold Significant Share in the Market

The strong presence of leading market players and rapid expansion of pharmaceutical and food sectors in the region are boosting the growth of North America synthetic lipids market. According to the U.S. Department of Agriculture, food, agriculture, and related industries contributed approximately USD 1.420 trillion to the GDP of the United States in 2022. Additionally, estimates suggest that the United States pharmaceutical industry generated USD 550 billion in 2021 in revenue. Due to the growth and expansion in food and pharmaceutical sectors in the region, the requirement for synthetic lipids is increasing as they find various applications in the sector. Owing to the success of mRNA vaccines, Moderna, a United States based biotechnology company is now working on the development of vaccines for a host of diseases including Zika, Malaria, tuberculosis, and HIV. Hence, the increase of research and development activities amongst leading pharmaceutical and biotechnological companies in the region will further boost the requirement for synthetic lipids, thus propelling the growth of the market.

Solid Synthetic Lipids Account for Significant Global Synthetic Lipids Market Share

The growth of the segment is supported by the increasing research activities conducted by various leading research institutions across the globe on solid lipid nanoparticles. For instance, these institutes include, the Department of Chemistry, Indian Institute of Technology Kharagpur. The researchers evaluated the stability and physicochemical characterizations and in vitro evaluations of CUR-loaded solid nanoparticles that were prepared with the help of biocompatible synthetic lipids. The solid lipid nanoparticles are showing promising results as drug delivery vehicles for ensuring the delivery of different drug types, especially poorly water-soluble drugs. The solid lipid nanoparticles can play an essential role in ensuring the delivery of curcumin in the disease sites with enhanced overall effects and improved bioavailability.

Rising Requirements from the Pharmaceutical Sector Aids Global Synthetic Lipids Market Growth

The increasing utilization of synthetic lipids for development of RNA therapies is boosting the growth of the market. MRNA-based systems are deployed for development of vaccines where viral proteins are identified as the potential candidates for vaccines. These systems are preferred as they are less prone to anti-vector immunity and genome integration. For instance, the recent success of BioNTech and Moderna has now resulted in the increase of clinical and preclinical studies of mRNA to other therapeutic and infectious disease applications, thus boosting the growth of the market. Moreover, the consistency and quality of lipids utilized in different pharmaceutical formulations is extremely essential. Lipid quality, type, and source are carefully considered prior to the initiation of the process as they directly impact the properties and impurity profile of the final drug. Furthermore, the choice of lipid impacts the particle characteristics, including release properties, structure, and stability. It is essential to control various impurities such as trans fatty acids in lipids as they can alter the RNA release and particle stability. Thus, synthetic lipids offer various advantages as opposed to natural lipids because the former is derived from a single lipid with known quality, and the chances of batch-to-batch variability are decreased. It, in turn, augments the demand for synthetic lipids and supports the growth of the market.

Key Players Landscape and Outlook

Global synthetic lipids market expansion is supported by increasing investments by leading market players towards the development of new lipid manufacturing plants. For instance, in March 2023, Evonik announced the opening of a new lipid manufacturing facility in Hanau, Germany. According to the company's chemical specialist the lipids produced will be used for gene therapies and RNA drugs aimed at cancer and infectious diseases, among others. The facility supports the production of proprietary as well as custom lipids. Such investments are expected to bolster synthetic

lipids' production, supporting the market's expansion.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Voice of Customer

  • 4.1.Market Awareness and Product Information
  • 4.2.Brand Awareness and Loyalty
  • 4.3.Factors Considered in Purchase Decision
    • 4.3.1.Brand Name
    • 4.3.2.Quality
    • 4.3.3.Quantity
    • 4.3.4.Price
    • 4.3.5.Product Specification
    • 4.3.6.Form Specification
    • 4.3.7.Shelf Life
    • 4.3.8.Availability of Product
  • 4.4.Frequency of Purchase
  • 4.5.Medium of Purchase

5.Global Synthetic Lipids Market Outlook, 2017-2031F

  • 5.1.Market Size & Forecast
    • 5.1.1.By Value
    • 5.1.2.By Volume
  • 5.2.By Form
    • 5.2.1.Solid
    • 5.2.2.Liquid
  • 5.3.By Application
    • 5.3.1.Personal Care and Cosmetics
    • 5.3.2.Pharmaceuticals
    • 5.3.3.Food
  • 5.4.By Region
    • 5.4.1.North America
    • 5.4.2.South America
    • 5.4.3.Europe
    • 5.4.4.Asia-Pacific
    • 5.4.5.Middle East & Africa
  • 5.5.By Company Market Share (%), 2023

6.Global Synthetic Lipids Market Outlook, By Region, 2017-2031F

  • 6.1.North America*
    • 6.1.1.Market Size & Forecast
      • 6.1.1.1.By Value
      • 6.1.1.2.By Volume
    • 6.1.2.By Form
      • 6.1.2.1.Solid
      • 6.1.2.2.Liquid
    • 6.1.3.By Application
      • 6.1.3.1.Personal Care and Cosmetics
      • 6.1.3.2.Pharmaceuticals
      • 6.1.3.3.Food
    • 6.1.4.United States*
      • 6.1.4.1.Market Size & Forecast
        • 6.1.4.1.1.By Value
        • 6.1.4.1.2.By Volume
      • 6.1.4.2.By Form
        • 6.1.4.2.1.Solid
        • 6.1.4.2.2.Liquid
      • 6.1.4.3.By Application
        • 6.1.4.3.1.Personal Care and Cosmetics
        • 6.1.4.3.2.Pharmaceuticals
        • 6.1.4.3.3.Food
    • 6.1.5.Canada
    • 6.1.6.Mexico

All segments will be provided for all regions and countries covered

  • 6.2.Europe
    • 6.2.1.Germany
    • 6.2.2.France
    • 6.2.3.Italy
    • 6.2.4.United Kingdom
    • 6.2.5.Russia
    • 6.2.6.Netherlands
    • 6.2.7.Spain
    • 6.2.8.Turkey
    • 6.2.9.Poland
  • 6.3.Asia-Pacific
    • 6.3.1.India
    • 6.3.2.China
    • 6.3.3.Japan
    • 6.3.4.Australia
    • 6.3.5.Vietnam
    • 6.3.6.South Korea
    • 6.3.7.Indonesia
    • 6.3.8.Philippines
  • 6.4.South America
    • 6.4.1.Brazil
    • 6.4.2.Argentina
  • 6.5.Middle East & Africa
    • 6.5.1.Saudi Arabia
    • 6.5.2.UAE
    • 6.5.3.South Africa

7.Supply Side Analysis

  • 7.1.Capacity, By Company
  • 7.2.Production, By Company
  • 7.3.Operating Efficiency, By Company
  • 7.4.Key Plant Locations (Up to 25)

8.Market Mapping, 2023

  • 8.1.By Form
  • 8.2.By Application
  • 8.3.By Region

9.Macro Environment and Industry Structure

  • 9.1.Supply Demand Analysis
  • 9.2.Import Export Analysis
  • 9.3.Supply Chain Analysis
  • 9.4.PESTEL Analysis
    • 9.4.1.Political Factors
    • 9.4.2.Economic System
    • 9.4.3.Social Implications
    • 9.4.4.Technological Advancements
    • 9.4.5.Environmental Impacts
    • 9.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 9.5.Porter's Five Forces Analysis
    • 9.5.1.Supplier Power
    • 9.5.2.Buyer Power
    • 9.5.3.Substitution Threat
    • 9.5.4.Threat from New Entrant
    • 9.5.5.Competitive Rivalry

10.Market Dynamics

  • 10.1.Growth Drivers
  • 10.2.Growth Inhibitors (Challenges and Restraints)

11.Key Players Landscape

  • 11.1.Competition Matrix of Top Five Market Leaders
  • 11.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 11.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 11.4.SWOT Analysis (For Five Market Players)
  • 11.5.Patent Analysis (If Applicable)

12.Pricing Analysis

13.Case Studies

14.Key Players Outlook

  • 14.1.CordenPharma
    • 14.1.1.Company Details
    • 14.1.2.Key Management Personnel
    • 14.1.3.Products & Services
    • 14.1.4.Financials (As reported)
    • 14.1.5.Key Market Focus & Geographical Presence
    • 14.1.6.Recent Developments
  • 14.2.Sigma-Aldrich (Merck Group)
  • 14.3.Merck Millipore
  • 14.4.Avanti Polar Lipids, Inc
  • 14.5.Lipoid GmbH
  • 14.6.NOF EUROPE GmbH
  • 14.7.Croda Pharma
  • 14.8.NucleoSyn
  • 14.9.Evonik Industries AG
  • 14.10.ABITEC Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

15.Strategic Recommendations

16.About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 2.Global Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 3.Global Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 4.Global Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 5.Global Synthetic Lipids Market Share (%), By Region, 2017-2031F
  • Figure 6.North America Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 7.North America Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 8.North America Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 9.North America Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 10.North America Synthetic Lipids Market Share (%), By Country, 2017-2031F
  • Figure 11.United States Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 12.United States Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 13.United States Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 14.United States Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 15.Canada Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 16.Canada Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 17.Canada Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 18.Canada Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 19.Mexico Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 20.Mexico Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 21.Mexico Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 22.Mexico Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 23.Europe Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 24.Europe Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 25.Europe Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 26.Europe Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 27.Europe Synthetic Lipids Market Share (%), By Country, 2017-2031F
  • Figure 28.Germany Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 29.Germany Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 30.Germany Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 31.Germany Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 32.France Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 33.France Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 34.France Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 35.France Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 36.Italy Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 37.Italy Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 38.Italy Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 39.Italy Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 40.United Kingdom Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 41.United Kingdom Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 42.United Kingdom Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 43.United Kingdom Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 44.Russia Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 45.Russia Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 46.Russia Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 47.Russia Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 48.Netherlands Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 49.Netherlands Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 50.Netherlands Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 51.Netherlands Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 52.Spain Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 53.Spain Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 54.Spain Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 55.Spain Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 56.Turkey Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 57.Turkey Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 58.Turkey Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 59.Turkey Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 60.Poland Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 61.Poland Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 62.Poland Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 63.Poland Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 64.South America Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 65.South America Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 66.South America Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 67.South America Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 68.South America Synthetic Lipids Market Share (%), By Country, 2017-2031F
  • Figure 69.Brazil Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 70.Brazil Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 71.Brazil Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 72.Brazil Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 73.Argentina Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 74.Argentina Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 75.Argentina Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 76.Argentina Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 77.Asia-Pacific Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 78.Asia-Pacific Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 79.Asia-Pacific Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 80.Asia-Pacific Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 81.Asia-Pacific Synthetic Lipids Market Share (%), By Country, 2017-2031F
  • Figure 82.India Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 83.India Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 84.India Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 85.India Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 86.China Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 87.China Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 88.China Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 89.China Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 90.Japan Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 91.Japan Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 92.Japan Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 93.Japan Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 94.Australia Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 95.Australia Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 96.Australia Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 97.Australia Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 98.Vietnam Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 99.Vietnam Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 100.Vietnam Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 101.Vietnam Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 102.South Korea Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 103.South Korea Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 104.South Korea Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 105.South Korea Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 106.Indonesia Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 107.Indonesia Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 108.Indonesia Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 109.Indonesia Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 110.Philippines Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 111.Philippines Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 112.Philippines Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 113.Philippines Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 114.Middle East & Africa Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 115.Middle East & Africa Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 116.Middle East & Africa Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 117.Middle East & Africa Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 118.Middle East & Africa Synthetic Lipids Market Share (%), By Country, 2017-2031F
  • Figure 119.Saudi Arabia Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 120.Saudi Arabia Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 121.Saudi Arabia Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 122.Saudi Arabia Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 123.UAE Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 124.UAE Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 125.UAE Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 126.UAE Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 127.South Africa Synthetic Lipids Market, By Value, In USD Billion, 2017-2031F
  • Figure 128.South Africa Synthetic Lipids Market, By Volume, in Kilotons, 2017-2031F
  • Figure 129.South Africa Synthetic Lipids Market Share (%), By Form, 2017-2031F
  • Figure 130.South Africa Synthetic Lipids Market Share (%), By Application, 2017-2031F
  • Figure 131.By Form Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 132.By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 133.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023